|
|
???tair.name??? >
???browser.page.title.author???
|
"mok king tong"???jsp.browse.items-by-author.description???
Showing items 1-11 of 11 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺大學術典藏 |
2018-09-10T14:57:15Z |
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
|
Liu, C.-J. and Chang, J. and Lee, P.-H. and Lin, D.-Y. and Wu, C.-C. and Jeng, L.-B. and Lin, Y.-J. and Mok, K.-T. and Lee, W.-C. and Yeh, H.-Z. and Ho, M.-C. and Yang, S.-S. and Yang, M.-D. and Yu, M.-C. and Hu, R.-H. and Peng, C.-Y. and Lai, K.-L. and Chang, S.S.-C. and Chen, P.-J.; Liu, Chun-Jen;Chang, Juliana;Lee, Po-Huang;Lin, Deng-Yn;Wu, Cheng-Chung;Jeng, Long-Bin;Lin, Yih-Jyh;Mok, King-Tong;Lee, Wei-Chen;Yeh, Hong-Zen;Ho, Ming-Chih;Yang, Sheng-Shun;Yang, Mei-Due;Yu, Ming-Chin;Hu, Rey-Heng;Peng, Cheng-Yuan;Lai, Kuan-Lang;Chang, Stanley Shi-Chung;Chen, Pei-Jer; 胡瑞恒;劉俊人;陳培哲;李伯皇;何明志; MING-CHIH HO; Liu, Chun-Jen; Chang, Juliana; CHUN-JEN LIU; Lee, Po-Huang; PEI-JER CHEN; REY-HENG HU; Lin, Deng-Yn; Wu, Cheng-Chung; Jeng, Long-Bin; Lin, Yih-Jyh; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Yang, Mei-Due; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer |
| 臺大學術典藏 |
2018-09-10T09:21:36Z |
Long-term results of a randomized, observation-controlled, phase III Trial of Adjuvant Interferon alfa-2b in hepatocellular carcinoma after curative resection
|
Chen, Miin-Fu; Li, Lung-An; Lee, Po-Huang; Lee, Po-Huang; Jeng, Long-Bin; Lin, Deng-Yn; Wu, Cheng-Chung; Mok, King-Tong; Chen, Chao-Long; Lee, Wei-Chen; Chau, Gar-Yang; Chen, Yaw-Sen; Lui, Wing-Yui; Hsiao, Chin-Fu; Hsiao, Chin-Fu; Whang-Peng, Jacqueline; Chen, Pei-Jer; Chen, Pei-Jer; Chen, L.-T. and Chen, M.-F. and Li, L.-A. and Lee, P.-H. and Jeng, L.-B. and Lin, D.-Y. and Wu, C.-C. and Mok, K.-T. and Chen, C.-L. and Lee, W.-C. and Chau, G.-Y. and Chen, Y.-S. and Lui, W.-Y. and Hsiao, C.-F. and Whang-Peng, J. and Chen, P.-J.; Chen, Li-Tzong;Chen, Miin-Fu;Li, Lung-An;Lee, Po-Huang;Jeng, Long-Bin;Lin, Deng-Yn;Wu, Cheng-Chung;Mok, King-Tong;Chen, Chao-Long;Lee, Wei-Chen;Chau, Gar-Yang;Chen, Yaw-Sen;Lui, Wing-Yui;Hsiao, Chin-Fu;Whang-Peng, Jacqueline;Chen, Pei-Jer; 陳培哲 ;李伯皇; Chen, Li-Tzong; Chen, Li-Tzong; PEI-JER CHEN |
| 臺大學術典藏 |
2018-09-10T09:14:11Z |
The binding affinity and molecular basis of the structure-binding relationship between urinary tamm-horsfall glycoprotein and tumor necrosis factor-α
|
Chang, Juliana; Li, Ko-Jen; Lee, Po-Huang; Siao, Sue-Cien; Siao, Sue-Cien; Chen, Yu-Hsuan; Chen, Yu-Hsuan; Lin, Deng-Yn; Wu, Tsai-Hung; Wu, Cheng-Chung; Wu, Tsai-Hung; Jeng, Long-Bin; Tsai, Chang-Youh; Tsai, Chang-Youh; Lin, Yih-Jyh; Yu, Chia-Li; Yu, Chia-Li; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Yang, Mei-Due; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer; 胡瑞恒; 劉俊人; 陳培哲; 李伯皇; 何明志; Wu, C.-H. and Li, K.-J. and Siao, S.-C. and Chen, Y.-H. and Wu, T.-H. and Tsai, C.-Y. and Yu, C.-L.; Wu, Cheng-Han;Li, Ko-Jen;Siao, Sue-Cien;Chen, Yu-Hsuan;Wu, Tsai-Hung;Tsai, Chang-Youh;Yu, Chia-Li; Wu, Cheng-Han;Li, Ko-Jen;Siao, Sue-Cien;Chen, Yu-Hsuan;Wu, Tsai-Hung;Tsai, Chang-Youh;Yu, Chia-Li; 余家利;吳政翰; Liu, Chun-Jen; Wu, Cheng-Han; CHENG-HAN WU; Wu, Cheng-Han; Li, Ko-Jen |
| 臺大學術典藏 |
2018-09-10T07:26:51Z |
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
|
Liu, C.-J. and Lee, P.-H. and Lin, D.-Y. and Wu, C.-C. and Jeng, L.-B. and Lin, P.-W. and Mok, K.-T. and Lee, W.-C. and Yeh, H.-Z. and Ho, M.-C. and Yang, S.-S. and Lee, C.-C. and Yu, M.-C. and Hu, R.-H. and Peng, C.-Y. and Lai, K.-L. and Chang, S.S.-C. and Chen, P.-J.; 劉俊人;李伯皇;胡瑞恆;吳誠中;鄭隆賓;林炳文;莫景棠;葉宏仁;何明志;楊勝舜;陳培哲; LIU, CHUN-JEN;LEE, PO-HUANG;HU, REY-HENG;WU, CHENG-CHUNG;JENG, LONG-BIN;LIN, PIN-WEN;MOK, KING-TONG;YEH, HONG-ZEN;HO, MING-CHIH;YANG, SHENG-SHUN;CHEN, PEI-JER; MING-CHIH HO; PO-HUANG LEE; CHUN-JEN LIU; PEI-JER CHEN; REY-HENG HU; LIU, CHUN-JEN; LEE, PO-HUANG; HU, REY-HENG; WU, CHENG-CHUNG; JENG, LONG-BIN; LIN, PIN-WEN; MOK, KING-TONG; YEH, HONG-ZEN; HO, MING-CHIH; YANG, SHENG-SHUN; CHEN, PEI-JER |
| 國立成功大學 |
2014-08-28 |
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
|
Liu, Chun-Jen; Chang, Juliana; Lee, Po-Huang; Lin, Deng-Yn; Wu, Cheng-Chung; Jeng, Long-Bin; Lin, Yih-Jyh; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Yang, Mei-Due; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer |
| 國立臺灣大學 |
2014 |
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
|
Liu, Chun-Jen; Chang, Juliana; Lee, Po-Huang; Lin, Deng-Yn; Wu, Cheng-Chung; Jeng, Long-Bin; Lin, Yih-Jyh; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Yang, Mei-Due; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer; 胡瑞恒; 劉俊人; 陳培哲; 李伯皇; 何明志 |
| 國立成功大學 |
2012-01 |
Long-Term Results of a Randomized, Observation-Controlled, Phase III Trial of Adjuvant Interferon Alfa-2b in Hepatocellular Carcinoma After Curative Resection
|
Chen, Li-Tzong; Chen, Miin-Fu; Li, Lung-An; Lee, Po-Huang; Jeng, Long-Bin; Lin, Deng-Yn; Wu, Cheng-Chung; Mok, King-Tong; Chen, Chao-Long; Lee, Wei-Chen; Chau, Gar-Yang; Chen, Yaw-Sen; Lui, Wing-Yui; Hsiao, Chin-Fu; Whang-Peng, Jacqueline; Chen, Pei-Jer |
| 國立臺灣大學 |
2012 |
Long-Term Results of a Randomized, Observation-Controlled, Phase III Trial of Adjuvant Interferon Alfa-2b in Hepatocellular Carcinoma After Curative Resection
|
Chen, Li-Tzong; Chen, Miin-Fu; Li, Lung-An; Lee, Po-Huang; Jeng, Long-Bin; Lin, Deng-Yn; Wu, Cheng-Chung; Mok, King-Tong; Chen, Chao-Long; Lee, Wei-Chen; Chau, Gar-Yang; Chen, Yaw-Sen; Lui, Wing-Yui; Hsiao, Chin-Fu; Whang-Peng, Jacqueline; Chen, Pei-Jer; 陳培哲; 李伯皇 |
| 國立成功大學 |
2009-05 |
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
|
Liu, Chun-Jen; Lee, Po-Huang; Lin, Deng-Yn; Wu, Cheng-Chung; Jeng, Long-Bin; Lin, Pin-Wen; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Lee, Ching-Chih; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer |
| 國立臺灣大學 |
2009 |
Heparanase Inhibitor Pi-88 as Adjuvant Therapy for Hepatocellular Carcinoma after Curative Resection: A Randomized Phase Ii Trial for Safety and Optimal Dosage
|
劉俊人; 李伯皇; 胡瑞恆; 吳誠中; 鄭隆賓; 林炳文; 莫景棠; 葉宏仁; 何明志; 楊勝舜; 陳培哲; LIU, CHUN-JEN; LEE, PO-HUANG; HU, REY-HENG; WU, CHENG-CHUNG; JENG, LONG-BIN; LIN, PIN-WEN; MOK, KING-TONG; YEH, HONG-ZEN; HO, MING-CHIH; YANG, SHENG-SHUN; CHEN, PEI-JER |
| 國立成功大學 |
2003-07 |
Compartment theory in Helicobacter pylori-associated gastric carcinogenesis
|
Tseng, Hui-Hwa; Hsu, Ping-I; Chen, Hui-Chun; Lai, Hui-Chun; Lo, Gin-Ho; Lo, Ching-Chu; Chou, Nan-Hua; Mok, King-Tong; Chen, I-Shu; Chou, Nan-Haw; Yang, Hsiao-Bai; Liu, Liu; Hsu, Ping-Ning |
Showing items 1-11 of 11 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
